BioCryst Pharmaceuticals (BCRX)
(Delayed Data from NSDQ)
$7.70 USD
-0.05 (-0.65%)
Updated Sep 17, 2025 04:00 PM ET
After-Market: $7.71 +0.01 (0.13%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
BioCryst Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
BCRX 7.70 -0.05(-0.65%)
Will BCRX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BCRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BCRX
Are Options Traders Betting on a Big Move in BCRX Stock?
BioCryst Pharmaceuticals (BCRX) Surpasses Q2 Earnings and Revenue Estimates
BCRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
BioCryst Pharmaceuticals Before Q2 Earnings: How to Play the Stock
Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for
BioCryst Pharmaceuticals (BCRX) Reports Next Week: Wall Street Expects Earnings Growth
Other News for BCRX
Is BCRX poised for a decline? Lower Bollinger Band Walk shows up after gaining 0.65%
BCRX forms Lower Bollinger Band Walk on September 15
BCRX forms Bollinger Band Squeeze on September 12
Is BCRX lining up for a decline? Death Cross shows up after climbing 0.75%
Is BCRX gaining bearish strength? Stochastic Reached Oversold shows up after dropping 0.87%